Illness Perceptions and Quality of Life in Patients with Diabetes Mellitus Type 2

Journal Title: Indonesian Journal of Clinical Pharmacy - Year 2017, Vol 6, Issue 3

Abstract

One of the treatment objectives in patients with type 2 diabetes mellitus (T2DM) is improving their quality of life (QoL). Illness perceptions are major determinant of QOL. This study was aimed to evaluate the QoL of T2DM patients with complications, and to examine the correlation between patients’ illness perceptions and QoL. We conducted a cross‑sectional study in a private hospital in Yogyakarta, Indonesia from July to September 2015. We recruited adult patients with a diagnosis of T2DM with complications (ICD E.11) that has been diagnosed for at least 3 months. Illness perceptions were assessed with the Brief Illness Perception Questionnaire (BIPQ), and diabetes type 2 specific QoL with the Diabetes Quality of Life for Clinical Trial Questionnaire (DQLCTQ). Data was analyzed using Pearson correlation test. We recruited 51 T2DM patients. Female patients were dominant and most of the subjects experienced T2DM more than 5 years. The BIPQ scores indicated that patients had positive perceptions about T2DM and the treatment in all domains, except for coherence. Scores on the DQLCTQ showed that T2DM patients’ QoL is good, except for the self satisfaction and treatment effect. Statistically significant positive correlations were observed between BIPQ dimensions of personal control, treatment control and coherence and QoL domains (p<0.01). Moreover, the strong negative correlation were observed between consequences, concern and emotional response and QoL domains (p<0.01). However, 92% correlations are weak. Illness perceptions are correlated with T2DM patients’ QoL. Interventions aimed to get more adaptive illness perceptions may impact positively on QoL.

Authors and Affiliations

Dyah A. Perwitasari, Setiyo B. Santosa, Imaniar N. Faridah, Adrian A. Kaptein

Keywords

Related Articles

The Difference of Kidney, Heart and Blood Function on Cervical Cancer Patients with Chemotherapy, Bleomycin, Oncovin®, Mitomycin and Carboplatin (Case Study in Sanglah General Hospital, Denpasar in 2015)

Oncovin® bleomycin mitomycin-carboplatin (BOM-carboplatin) regimen as chemotherapy is inseparable from the side effects it can caused which is toxicity to organs including the kidneys, liver, and blood where the toxicity...

Metformin Enhances Anti-proliferative Effect of Cisplatin in Cervical Cancer Cell Line

Cervival cancer is one of the top rank of gynecological malignancy in the world, leading to high morbidity and mortality rates. Cisplatin is a chemotherapeutic agent that is generally used to treat cervical cancer but th...

Health-Related Quality of Life of Type 2 Diabetes Mellitus Outpatients at Dr. Sardjito Hospital, Yogyakarta, Indonesia: An Insulin-Based Therapy Approach

Diabetes mellitus type 2 is a lifelong disease which needs an intensive therapy to maintain stable blood sugar levels. Insulin has been proven as an effective treatment modality for type 2 diabetes mellitus patient. The...

The Roles of Employee Engagement as Organization Culture Mediator in Hospital Pharmacy Employees

The aims of the study are to analyze the relationship of organization culture on individual performance, customer satisfaction and employee engagement as mediation role in the installation of the hospital pharmacy. A tot...

Glycemic Control and Prevalence of Chronic Kidney Disease in Type‑2 Diabetes Mellitus Patients at Primary Healthcare Centers in Yogyakarta Province 2015

Good glycemic control in type-2 diabetes mellitus (T2DM) has proven to be able to prevent complications. Primary healthcare is at the forefront being expected to provide good services in T2DM management for preventing su...

Download PDF file
  • EP ID EP370110
  • DOI 10.15416/ijcp.2017.6.3.190
  • Views 124
  • Downloads 0

How To Cite

Dyah A. Perwitasari, Setiyo B. Santosa, Imaniar N. Faridah, Adrian A. Kaptein (2017). Illness Perceptions and Quality of Life in Patients with Diabetes Mellitus Type 2. Indonesian Journal of Clinical Pharmacy, 6(3), 190-199. https://europub.co.uk/articles/-A-370110